Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exogenous progestagens and the human breast.

Regine Sitruk-Ware1, Genevieve Plu-Bureau

  • 1Population Council, Rockefeller University, New York, NY 10021, USA. regine@popcbr.rockefeller.edu

Maturitas
|September 8, 2004
PubMed
Summary

Progestin effects on breast tissue are complex and debated. While some progestins may decrease breast cancer risk, prolonged use, especially in postmenopausal women, can increase it, necessitating further research.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vascular risk at menopause: The importance of a cardio-gynecological program.

Maturitas·2026
Same author

Low dose intranasal nestorone self-emulsifying drug delivery system promotes neuroprotection in experimental stroke through modulation of glial cells.

Drug delivery and translational research·2026
Same author

[A targeted approach to cardiovascular risk in women: towards improved screening and prevention].

Medecine sciences : M/S·2026
Same author

[Establishment of the Port-Royal menopause university center. Inform, screen, and provide care].

Medecine sciences : M/S·2026
Same author

[Menopause, hormone therapy and cardiovascular risk].

Medecine sciences : M/S·2026
Same author

Risk of cardiovascular disease and mortality among women with endometriosis: A systematic review and meta-analysis.

Acta obstetricia et gynecologica Scandinavica·2025

Area of Science:

  • Endocrinology
  • Oncology
  • Cell Biology

Background:

  • The role of progestins in breast tissue is controversial, with varying effects on cell proliferation, differentiation, and apoptosis.
  • Progestins are utilized in treating metastatic breast cancer and hormone replacement therapy (HRT).
  • Different progestin structures can lead to diverse biological activities, including androgenic, estrogenic, or glucocorticoid effects.

Purpose of the Study:

  • To review the current understanding of progestin actions on breast cells.
  • To explore the relationship between progestin use, breast cancer risk, and HRT.
  • To identify knowledge gaps regarding progestin receptor binding and clinical relevance.

Main Methods:

  • Literature review of studies on progestin effects on breast tissue.
  • Analysis of data on breast cancer risk associated with different progestin types and durations of use.
  • Examination of in vitro studies on progestin-induced cell proliferation and apoptosis.

Main Results:

  • Progestins can induce cell differentiation and apoptosis, potentially overriding proliferation depending on the molecule and duration.
  • Long-term use of 19-nortestosterone progestins may decrease breast cancer risk in young women, contrasting with postmenopausal estrogen use.
  • Some androgenic progestins stimulate MCF7 cell proliferation, while progesterone-derived progestins do not.

Conclusions:

  • Different progestins exert varied effects on breast cells, with potential clinical relevance still under investigation.
  • While short-term HRT (≤5 years) appears to carry a low risk, prolonged progestin use may increase breast cancer risk.
  • Further randomized, long-term prospective studies are crucial to elucidate optimal HRT regimens and the specific effects of various progestins on breast cell responses.

Related Experiment Videos